OMHE (Omni Health) Research & Development: $0.00 Mil (TTM As of Jan. 2017)


What is Omni Health Research & Development?

Omni Health OMHE -96.67% Research & Development is $0.00 Mil as of Jan. 2017.

Research & Development is the aggregate amount of research and development expenses during the year. Omni Health's Research & Development for the three months ended in Jan. 2017 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jan. 2017 was $0.00 Mil.

Omni Health  (OTCPK:OMHE) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Omni Health Research & Development Related Terms

Omni Health Research & Development Historical Data

* Premium members only.

The historical data trend for Omni Health's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omni Health Research & Development Chart

Omni Health Annual Data
Trend Apr14 Apr15 Apr16
Research & Development
0.00 0.00 0.00

Omni Health Quarterly Data
Apr14 Jul14 Oct14 Jan15 Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Omni Health Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jan. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Omni Health (OMHE) has a Research & Development of $0.00 Mil as of Jan. 2017. Research and development expense is the total cost for research and development activities. View historical data on Omni Health and its competitors.
Is Omni Health's Research & Development too high?
Omni Health's current Research & Development is $0.00 Mil.
How does Omni Health's Research & Development compare to MYDP and HEWA?
Omni Health's Research & Development of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Omni Health and its competitors. Omni Health's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omni Health stock overvalued right now?
Omni Health (OMHE) has a current Research & Development of $0.00 Mil. The current Research & Development is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Omni Health (OMHE), the current Research & Development is $0.00 Mil as of Jan. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Omni Health Business Description

Address 400 W 41st Street, Suite 506, Miami Beach, FL, USA, 33140
Omni Health Inc is a vertically integrated healthcare company operating a pharmacy provider and focused on developing and distributing anti-aging products.